Clinical trial
Thalamic Deep Brain Stimulation for Tourette Syndrome
NCT00311909 · University Hospitals Cleveland Medical Center, Other · Completed
Key facts
| NCT number | NCT00311909 |
|---|---|
| Title | Thalamic Deep Brain Stimulation for Tourette Syndrome |
| Official title | Thalamic Deep Brain Stimulation for Tourette Syndrome: A Prospective Clinical Trial |
| Lead sponsor | University Hospitals Cleveland Medical Center, Other |
| Collaborators | Medtronic Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tourette Syndrome |
| Intervention type | Device |
| Interventions | Thalamic deep brain stimulation |
| Enrollment | 5 |
| Start date | Jun 1, 2005 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Apr 6, 2006 |
| Last update posted | May 12, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: